Psychologic Dyspareunia

Categories: Mental diseases

Aliases & Classifications for Psychologic Dyspareunia

MalaCards integrated aliases for Psychologic Dyspareunia:

Name: Psychologic Dyspareunia 12 69
Dyspareunia, Psychogenic 12
Non-Organic Dyspareunia 12


External Ids:

Disease Ontology 12 DOID:11120
ICD10 33 F52.6
ICD9CM 35 302.76
UMLS 69 C0154466

Summaries for Psychologic Dyspareunia

MalaCards based summary : Psychologic Dyspareunia, is also known as dyspareunia, psychogenic. The drugs Bupivacaine and Triamcinolone have been mentioned in the context of this disorder. Affiliated tissues include bone.

Related Diseases for Psychologic Dyspareunia

Symptoms & Phenotypes for Psychologic Dyspareunia

Drugs & Therapeutics for Psychologic Dyspareunia

Drugs for Psychologic Dyspareunia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 91)
id Name Status Phase Clinical Trials Cas Number PubChem Id
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
Drospirenone Approved Phase 4 67392-87-4 68873
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-28-2 5757
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
Acetylcholine Approved Phase 4,Phase 3 51-84-3 187
Menthol Approved Phase 4 2216-51-5 16666
Tamoxifen Approved Phase 4 10540-29-1 2733526
Lidocaine Approved, Vet_approved Phase 4,Phase 3 137-58-6 3676
Loperamide Approved Phase 4,Early Phase 1 53179-11-6 3955
Glycerol Approved, Investigational Phase 4 56-81-5 753
Mineral oil Approved, Vet_approved Phase 4 8042-47-5
13 Anesthetics Phase 4,Phase 3
14 Anesthetics, Local Phase 4,Phase 3
15 Anti-Inflammatory Agents Phase 4
16 Central Nervous System Depressants Phase 4,Phase 3
17 glucocorticoids Phase 4
18 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
19 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
20 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
21 Immunosuppressive Agents Phase 4
22 Peripheral Nervous System Agents Phase 4,Phase 3
23 triamcinolone acetonide Phase 4
24 Triamcinolone diacetate Phase 4
25 Triamcinolone hexacetonide Phase 4
26 Contraceptive Agents Phase 4,Phase 3,Phase 2
27 Contraceptives, Oral Phase 4,Phase 3
28 diuretics Phase 4
29 Diuretics, Potassium Sparing Phase 4,Phase 3
30 Drospirenone and ethinyl estradiol combination Phase 4
31 Estradiol 17 beta-cypionate Phase 4,Phase 3,Phase 2
32 Estradiol 3-benzoate Phase 4,Phase 3,Phase 2
33 Estradiol valerate Phase 4,Phase 3,Phase 2 979-32-8
34 Estrogens Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
35 Mineralocorticoid Receptor Antagonists Phase 4
36 Mineralocorticoids Phase 4
37 Natriuretic Agents Phase 4
38 Polyestradiol phosphate Phase 4,Phase 3,Phase 2
39 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1
40 abobotulinumtoxinA Phase 4,Phase 3
41 Botulinum Toxins Phase 4,Phase 3
42 Botulinum Toxins, Type A Phase 4,Phase 3
43 Cholinergic Agents Phase 4,Phase 3
44 Neuromuscular Agents Phase 4,Phase 3
45 Neurotransmitter Agents Phase 4,Phase 3
46 onabotulinumtoxinA Phase 4,Phase 3
47 Bone Density Conservation Agents Phase 4
48 Estrogen Antagonists Phase 4,Phase 1,Phase 2,Early Phase 1
49 Estrogen Receptor Modulators Phase 4
50 Selective Estrogen Receptor Modulators Phase 4

Interventional clinical trials:

(show all 41)

id Name Status NCT ID Phase Drugs
1 Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain Unknown status NCT02022722 Phase 4 Trigger Point Injections Triamcinolone Acetonide, Bupivacaine Hydrochloride
2 Continuous Versus Cyclic Oral Contraceptives for Endometriosis Unknown status NCT02237131 Phase 4 Oral contraceptives cyclic;Oral contraceptives continuous
3 Dilators for Dyspareunia Prevention Completed NCT01299363 Phase 4
4 Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA Completed NCT02784613 Phase 4 Ospemifene
5 Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia Recruiting NCT01935063 Phase 4
6 Treating Where it Hurts Recruiting NCT03240081 Phase 4 50mcg estradiol cream;100mcg estradiol cream
7 A Trial of Pelvic Floor Chemodenervation in Patients Undergoing Physical Therapy for High Tone Pelvic Floor Dysfunction Recruiting NCT03199534 Phase 4 Botulinum toxin A 50u;Botulinum toxin A 150u
8 The Vaginal Health Trial Active, not recruiting NCT02516202 Phase 4 Vagifem;Replens
9 Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Experiencing Treatment-Induced Menopause: a Multicenter Randomized Trial Unknown status NCT00582244 Phase 3
10 Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg) Unknown status NCT00458458 Phase 3 Norethindrone Acetate (NA);GnRH Agonist (Lupron Depot)
11 Botulinum Toxin Injection for Treatment of Vaginismus Unknown status NCT00638066 Phase 3 botulinum toxin;botulinum toxin A
12 Savella in Treatment for Provoked Vestibulodynia Completed NCT01304589 Phase 3 Milnacipran
13 Study to Evaluate Safety & Efficacy of WC3011 in Postmenopausal Women With Dyspareunia Completed NCT01845649 Phase 3 Estradiol Vaginal Gel;Vehicle
14 Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women Completed NCT02253173 Phase 3 Estradiol;Placebo
15 Therapy to Prevent Sexual Pain in Breast Cancer Survivors Completed NCT01539317 Phase 3 Topical liquid lidocaine;Topical saline
16 Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women Completed NCT00318500 Phase 2 ERB-041
17 A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy Completed NCT02670785 Phase 2 Estradiol Vaginal Capsule (EVC);Placebo
18 TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy Completed NCT02449902 Phase 2 Estradiol;placebo
19 Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer. Suspended NCT01122342 Phase 1, Phase 2 Testosterone propionate
20 Use of Estriol at Distal Third of Vagina Improving Coital Pain in Post-menopause Women Not yet recruiting NCT03116022 Phase 1 Estriol;Distal estriol;Vaginal Gel
21 Efficacy of Transcranial Direct-Current Stimulation (tDCS) for Provoked Vestibulodynia : a Triple Blind Randomized Controlled Trial Completed NCT02543593
22 Efficacy of a Physiotherapy Treatment in Women Suffering From Provoked Vestibulodynia Completed NCT01455350 lidocaine
23 Physiotherapy Intervention in Climacteric Women With Dyspareunia Completed NCT02804048
24 Postpartum Dyspareunia Resulting From Vaginal Atrophy Completed NCT01319968 Estriol 0.1% vaginal cream
25 Outcomes of Delivery in Patients With Dyspareunia Completed NCT01753258
26 Sexual Dysfunction and Dental Care Completed NCT00281372
27 Acupuncture for the Treatment of Vulvodynia Completed NCT02197429
28 Life-Stress Interview for Women With Chronic Urogenital Pain Conditions Completed NCT02286115
29 Acupuncture for Vulvodynia: A Pre-pilot Study Completed NCT02704234
30 Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy Completed NCT01697345 Early Phase 1 Testosterone
31 Multi-point Intra-mucosal Injections of Cross-linked Hyaluronic Acid (DESIRIAL®) in the Vaginal Vestibule Recruiting NCT02739880
32 Trans-perineal Trigger Point Dry Needling for Chronic Pelvic Pain Recruiting NCT02795026
33 Electrolysis Technique vs Manual Therapy in Pelvic Pain Recruiting NCT03163160
34 Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause Recruiting NCT03178825
35 GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors Recruiting NCT03185169 Early Phase 1
36 Rapidly Absorbing Polyglactin 910 Versus Monocryl for Laceration Repair Active, not recruiting NCT03184077
37 Dyspareunia and Central Sensitization Enrolling by invitation NCT03216330
38 Dyspareunia in Women With Endometriosis: Impact of Surgery on Sexual Health Not yet recruiting NCT02484196
39 Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors Not yet recruiting NCT03257670 4% Topical Lidocaine Gel
40 Low Level Laser Therapy for the Treatment of Provoked Vestibulodynia Terminated NCT01149031
41 Randomized Trial of Interrupted Versus Continuous Vaginal Closure of Anterior Repair With Mesh Withdrawn NCT00676000

Search NIH Clinical Center for Psychologic Dyspareunia

Genetic Tests for Psychologic Dyspareunia

Anatomical Context for Psychologic Dyspareunia

MalaCards organs/tissues related to Psychologic Dyspareunia:


Publications for Psychologic Dyspareunia

Variations for Psychologic Dyspareunia

Expression for Psychologic Dyspareunia

Search GEO for disease gene expression data for Psychologic Dyspareunia.

Pathways for Psychologic Dyspareunia

GO Terms for Psychologic Dyspareunia

Sources for Psychologic Dyspareunia

9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
32 HPO
33 ICD10
34 ICD10 via Orphanet
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
52 Novoseek
55 OMIM via Orphanet
59 PubMed
66 SNOMED-CT via Orphanet
68 Tocris
70 UMLS via Orphanet
Loading form....